Zealand Pharma A/S (ZLDPF)
35.64
-1.90
(-5.05%)
USD |
OTCM |
Oct 09, 16:00
Zealand Pharma Free Cash Flow (Quarterly) : 61.68M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 61.68M |
| March 31, 2026 | -106.96M |
| December 31, 2025 | -175.83M |
| September 30, 2025 | -32.65M |
| June 30, 2025 | 1.288B |
| March 31, 2025 | -71.89M |
| December 31, 2024 | -23.02M |
| September 30, 2024 | -43.57M |
| June 30, 2024 | -34.26M |
| March 31, 2024 | -33.07M |
| December 31, 2023 | 7.084M |
| September 30, 2023 | -17.86M |
| June 30, 2023 | -26.06M |
| March 31, 2023 | -28.51M |
| December 31, 2022 | -38.25M |
| September 30, 2022 | -17.10M |
| June 30, 2022 | -30.24M |
| March 31, 2022 | -48.36M |
| December 31, 2021 | -45.39M |
| September 30, 2021 | -30.94M |
| June 30, 2021 | -52.98M |
| March 31, 2021 | -60.35M |
| December 31, 2020 | -43.67M |
| September 30, 2020 | -17.77M |
| June 30, 2020 | -16.51M |
| Date | Value |
|---|---|
| March 31, 2020 | -31.86M |
| December 31, 2019 | -25.76M |
| September 30, 2019 | -24.53M |
| June 30, 2019 | -21.03M |
| March 31, 2019 | 7.392M |
| December 31, 2018 | -22.99M |
| September 30, 2018 | -15.74M |
| June 30, 2018 | -17.85M |
| March 31, 2018 | -15.41M |
| December 31, 2017 | -17.35M |
| September 30, 2017 | -1.684M |
| June 30, 2017 | -18.51M |
| March 31, 2017 | -7.694M |
| December 31, 2016 | 16.76M |
| September 30, 2016 | -6.915M |
| June 30, 2016 | -9.606M |
| March 31, 2016 | 6.089M |
| December 31, 2015 | -6.802M |
| September 30, 2015 | -9.302M |
| June 30, 2015 | -8.765M |
| March 31, 2015 | -9.282M |
| December 31, 2014 | -6.421M |
| September 30, 2014 | 0.789M |
| June 30, 2014 | -9.552M |
| March 31, 2014 | 7.184M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Genmab A/S | 48.05M |
| Ascendis Pharma A/S | 323.81M |
| Bavarian Nordic A/S | 46.98M |
| Evaxion AS | -- |
| ACADIA Pharmaceuticals, Inc. | 95.69M |